Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)

ClinicalTrials.gov ID: NCT03987074

Public ClinicalTrials.gov record NCT03987074. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 10:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Proof of Concept, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Subjects With Nonalcoholic Steatohepatitis (NASH)

Study identification

NCT ID
NCT03987074
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
109 participants

Conditions and interventions

Interventions

  • Cilofexor Drug
  • Firsocostat Drug
  • Semaglutide Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 28, 2019
Primary completion
Jul 12, 2020
Completion
Jul 12, 2020
Last update posted
Jul 14, 2021

2019 – 2020

United States locations

U.S. sites
18
U.S. states
10
U.S. cities
17
Facility City State ZIP Site status
Institute for Liver Health - Arizona Liver Health Chandler Arizona 85224
Southern California Research Centers Coronado California 92118
University of California San Diego (UCSD) La Jolla California 92093
Ruane Clinical Research Group, Inc Los Angeles California 90036
Cedars Sinai Medical Center Los Angeles California 90048
Inland Empire Clinical Trials, LLC Rialto California 92377
Medical Associates Research Group San Diego California 92123
Gastrointestinal Specialists of Georgia Marietta Georgia 30060
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Jubilee Clinical Research, Inc. Las Vegas Nevada 89109
Northwell Health Manhasset New York 11030
Gastro One Huntersville North Carolina 28078
University Gastroenterology Providence Rhode Island 02905
Gastro One Germantown Tennessee 38138
Quality Medical Research, PLLC Nashville Tennessee 37211
Texas Clinical Research Institute Arlington Texas 76012
The Liver Institute at Methodist Dallas Medical Center Dallas Texas 75203
American Research Corporation San Antonio Texas 78215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03987074, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 14, 2021 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03987074 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →